We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Global Opportunities Trust Plc | LSE:GOT | London | Ordinary Share | GB0033862573 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 288.00 | 284.00 | 290.00 | - | 12,300 | 15:47:59 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investment Advice | 15.68M | 14.68M | 0.5025 | 5.73 | 84.16M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/12/2023 16:15 | 17% discount to NAV. Certainly hedging their bets with this portfolio! Nov 23 factsheet. Cash 39.7% Templeton European Long-Short Equity SIF 14.5% Volunteer Park Capital Fund 7.6% TotalEnergies Energy France 3.6% Unilever Consumer Staples United Kingdom 2.7% ENI Energy 2.7% Samsung Electronics Information Technology 2.6% Sumitomo Mitsui Trust Holdings 2.6% Orange Communication Services 2.5% Panasonic 2.1% General Dynamics Industrials United States 2,151,981 2.0 | hugepants | |
30/5/2023 10:17 | I've recently topped-up here. Dr Sandy Nairn has called it right so far. I'm reasonably confident that he will protect capital and move back into equities at the right time. Yield is disappointing, but that may rise at some point given their defensive positioning. | topvest | |
30/3/2023 20:53 | Re management arrangements: The Company is pleased to announce that, effective today, Dr Sandy Nairn has been appointed as a full time executive of the Company, having resigned from his executive position with Franklin Templeton. The Company is taking steps to terminate its investment management agreement with Franklin Templeton Investment Management Limited (the "IMA"), such termination currently expected to be effective by mid-May 2023, and the global listed equities portion of the Company's portfolio will be managed by Dr Nairn going forward. The Company thanks Franklin Templeton for its services to date and throughout the Company's transition to a self-managed structure. The Company is also pleased to announce that it has entered into a strategic relationship with Goodhart Partners LLP ("Goodhart") through which Goodhart will introduce opportunities in the private markets to the Company. As part of this strategic relationship, terms have also been agreed with Goodhart to provide investment sub-advisory services to the Company to assist Dr Nairn in managing the global listed equities mandate and the FX arrangements. | rambutan2 | |
30/3/2023 20:46 | Worth reading yesterday's rather good results via the full Annual Report which is available on the website (see link in header): Cahal Dowds, Chairman - "This is the first full year of the Company operating under its expanded investment policy. As was articulated in the shareholder circular which preceded the changes, the Board felt strongly that such were the excessive conditions in asset markets, greater flexibility was required in order to protect shareholder capital. I am pleased to report that the results for 2022 have supported this view, with the NAV total return of the Company appreciating by 15.8% and the total return to shareholders of the share price, with dividends reinvested, rising by 9.8%. This was against a backdrop of synchronised declines in almost all asset classes. Shareholders should note that a substantial component of the positive return relates to the decline of sterling. However, even without the currency effect, the assets of the Company would have appreciated. | rambutan2 | |
29/3/2023 07:10 | Interesting news today. Getting Sandy Nairn full-time | nfs | |
19/2/2023 21:42 | Holdings as at end Jan. Two things to note. A large cash position has been held for a long time now, helping on the downside, but of course dragging on any upside. And the largest position, a long/short hedge fund, performed very well last year. | rambutan2 | |
19/2/2023 21:38 | No thread for this differentiated Sandy Nairn investment vehicle, so here we go... | rambutan2 | |
19/6/2018 10:39 | GoTech announces that at its general meeting held earlier today, all resolutions were passed, including the resolution to approve the proposed cancellation of the admission of the Company's ordinary shares of 0.1 pence each ("Ordinary Shares") to trading on AIM. Trading in the Company's Ordinary Shares on AIM will be suspended with effect from 7.30am on 21 June 2018 pursuant to AIM Rule 15. Therefore, the last day of dealings in the Company's Ordinary Shares on AIM will be 20 June 2018 and at 7.00 a.m. on 25 June 2018, the Company's Ordinary Shares will be cancelled from trading on AIM. As detailed in the Company's announcement of 11 June 2018, the Company has made an application for its Ordinary Shares to be admitted to trading on the NEX Exchange Growth Market ("NEX") and it is anticipated that dealings in the Company's Ordinary Shares on NEX will commence at 8.00 a.m. on 25 June 2018. | lordz | |
19/6/2018 10:37 | Shareholders should note that trading in the Company's Ordinary Shares on AIM will be suspended with effect from 7.30am on 21 June 2018pursuant to AIM Rule 15. Admission of the Ordinary Shares to trading on NEX cannot occur if the Cancellation Resolution is not approved and the Cancellation does not occur.All resolutions are all duly passed. | lordz | |
19/6/2018 07:35 | https://www.google.c | imjustdandy | |
19/6/2018 06:37 | The war on cannabis has been lost, the Government should be bold and legalise it, Lord Hague tells Prime Minister | imjustdandy | |
14/6/2018 05:26 | https://mobile.twitt | imjustdandy | |
01/6/2018 11:04 | Interesting move up | solarno lopez | |
25/5/2018 13:18 | And he was one of the poor sods in the 0.04p placing ! | solarno lopez | |
25/5/2018 13:14 | Chris Akers has upped his stake !! | solarno lopez | |
25/5/2018 07:53 | The poor sods who backed this in the recent placings at 0.04 must be sick | solarno lopez | |
24/5/2018 11:52 | MMs don't want stock so any selling will push the price south and well south Clearly designed to benefit the Loan Stock holder Vote against is my suggestion | solarno lopez | |
24/5/2018 10:31 | I have two options, firstly to vote against the proposals and secondly to sell my stock | solarno lopez | |
24/5/2018 07:17 | Shame it's delisting, had it on my monitor. Won't bother now. Gla | still waiting | |
24/5/2018 07:15 | Its the Peterhouse format ! | solarno lopez | |
24/5/2018 07:14 | The loan notes look a real cheek - "Lower of" 0.4p or 10% discount to bid price, ie "can't lose". Higher of would be much more reasonable. Who knows what the quote will be on NEX admission, but if it's (inevitably) wide, the conversion is at 10% below the low bid. | spectoacc | |
24/5/2018 07:03 | clearly not a welcome move | solarno lopez | |
24/5/2018 06:15 | Sounds positive to me but you missed the all important point about its new investment strategy into medicinal products | solarno lopez |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions